/
J Clin Endocrinol Metab
Glucagon decreases IGF-1 bioactivity in humans, independently of insulin, by modulating its binding proteins
- Z. Sarem
- C. Bumke-Vogt
- A.M. Mahmoud
- B. Assefa
- M.O. Weickert
- A. Adamidou
- V. Baehr
- J. Frystyk
- M. Moehlig
- J. Spranger
- S. Lieske
- A.L. Birkenfeld
- A.F.H. Pfeiffer
- A.M. Arafat